Every so often, I like to take a look to see which shares have experienced meaningful insider buying. This is because insider buying is often regarded as a bullish indicator, as few people know a company and its intrinsic value better than its own directors.
A number of shares have reported meaningful insider buying this month. Here are a couple which have caught my eye:
Medical Developments International Ltd (ASX: MVP)
According to a change of director’s interest notice, one of this medical device company’s directors has been buying shares this week.
The notice reveals that its new non-executive director, Mary Sontrop, bought a total of 18,630 shares through an on-market trade on Monday. Ms Sontrop paid an average of $5.3706 per share, which equates to a total consideration of ~$100,000.
Ms Sontrop has moved quickly to align her interests with shareholders. She was only appointed as a Non-Executive Director last week. The new director has extensive international experience in the biopharmaceutical sector across manufacturing operations, quality, and business integration. During her 28 years with CSL Limited (ASX: CSL), she was an integral part of CSL’s globalisation through a series of major acquisitions.
Interestingly, this is just the latest in a number of former CSL executive to join the company. Late last year ex-CSL execs Brent MacGregor and Gordon Naylor joined as CEO and Chairman, respectively.
Sydney Airport Holdings Pty Ltd (ASX: SYD)
A change of director’s interest notice reveals that one of this airport operator’s directors almost doubled their holding last week. According to the notice, non-executive director Abigail Cleland picked up 17,070 shares through an on-market trade on Thursday of last week.
The release reveals that Cleland paid an average of $5.83 per share, which equates to a total consideration of ~$99,500. This lifted her holding to a total of 34,983 shares.
With the Sydney Airport share price still down 21% from its 52-week high, it appears as though this director sees value in its shares.
Once broker that would agree is Goldman Sachs. It currently has a buy rating and $6.73 price target on Sydney Airport’s shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
More reading
- The Medical Developments International (ASX:MVP) share price is jumping 7% today
- ASX 200 Weekly Wrap: ASX finishes higher, despite tech selloff
- ASX 200 Weekly Wrap: Friday carnage ruins last week of ASX earnings
- Where next for the Sydney Airport (ASX:SYD) share price?
- Sydney Airport (ASX:SYD) share price receives a boost on full-year results
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Insiders have been buying Sydney Airport (ASX:SYD) and this ASX share appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3emufPm
Leave a Reply